D. Krause

发表

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

D. Prockop, F. Marini, A. Keating, 2006, Cytotherapy.

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

F. Marini, A. Keating, E. Horwitz, 2005, Cytotherapy.

Molecular Pathogenesis of Polycythemia Induced in Mice by JAK2 V617F.

Yiguo Hu, R. A. Etten, Shaoguang Li, 2005 .

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial

K. Cornetta, B. Burtness, D. Krause, 2000, Bone Marrow Transplantation.

A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells

A. Psyrri, B. Burtness, D. Krause, 1999, Bone Marrow Transplantation.

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

K. Cornetta, D. Blaise, M. Shlomchik, 1998, British Journal of Cancer.

CD34: structure, biology, and clinical utility.

M. Fackler, C. Civin, W. May, 1996, Blood.

Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.

M. Griffith, M. Prilutskaya, D. Krause, 2001, Cytotherapy.

A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents

Y. Wu, D. Krause, S. Seropian, 2003, Bone Marrow Transplantation.

Toward a new paradigm of cell plasticity

D. Krause, ND Theise, DS Krause, 2002, Leukemia.